September 10, 2025BiomedicinesOpen Access

Fulminant Myocarditis with VA-ECMO Support: Clinical Characteristics and Prognosis in a Cohort from a Tertiary Transplant Center

View Full Paper

Ask AI

Bookmark

Authors

BCBorja Guerrero Cervera RLRaquel López‐Vilella RCRicardo Costa

Discussion

Member takes

Implication

Observational study details the prognosis and complications of fulminant myocarditis in patients with VA-ECMO support, suggesting important recovery indicators.

Key Points

In-hospital survival rates were significantly higher in patients who recovered from fulminant myocarditis.
Patients with myocardial fibrosis on MRI showed a lower likelihood of recovery and worse systemic health indicators.
Patients requiring longer ECMO support had significantly poorer recovery outcomes and more complications.
Echocardiographic outcomes indicated better cardiac function in the recovery group compared to those who did not recover.

Cite This Study

Cervera et al. (2025) studied this question.

synapsesocial.com/papers/68c23b08b210217d64782bbb https://doi.org/10.3390/biomedicines13092146

View Full Paper

Ask AI

Bookmark

Implication

Observational study details the prognosis and complications of fulminant myocarditis in patients with VA-ECMO support, suggesting important recovery indicators.

Fulminant Myocarditis with VA-ECMO Support: Clinical Characteristics and Prognosis in a Cohort from a Tertiary Transplant Center

Discussion

Member takes

Implication

Key Points

Cite This Study

Fulminant Myocarditis with VA-ECMO Support: Clinical Characteristics and Prognosis in a Cohort from a Tertiary Transplant Center

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider